Elan Pharma (India) Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 1997.
1997 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Elan Pharma (India) Private Limited

Elan Pharma (India) Private Limited, a active private limited company, was established on 04 June 1997 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230MH1997PTC108497. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹0.94 M.

It upholds a compliant status. Employing 321 professional, Its leadership includes Dandu Vijay Prakash Raju (Managing Director), Vidyadhar Dadu Sawant (Whole-Time Director). Past directors included Prakash Gunaji Sawardekar, Joseph Peter Sequeira, Vidyadhar Dadu Sawant. It holds no open charges and ₹4.93 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 501-Raikar Chambers Govandi, Deonar,, Mumbai, Maharashtra, 400088.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230MH1997PTC108497

  • Registration Number

    108497

  • Incorporation Date

    04 June 1997

  • Authorized Capital

    ₹2.50 M

  • Paid-Up Capital

    ₹0.94 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.50 M
  • Paid Up Capital ₹ 0.94 M
  • Company Age 28 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Satisfied Charges ₹ 4.93 Cr
  • Revenue Growth **** 18.68%
  • Profit Growth **** 18.65%
  • Ebitda **** 18.24%
  • Net Worth 20.44%
  • Total Assets **** 17.63%
Company report

Elan Pharma (India) Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Elan Pharma (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Elan Pharma (India) Private Limited?
Current Directors
Name Designation Appointment Date Status
Dandu Vijay Prakash Raju Managing Director 04 Jun 1997 Current
Vidyadhar Dadu Sawant Whole-Time Director 07 Sep 2013 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Feb 2009 Past
Pramod Abcsdd Whole-Time Director 01 Nov 2015 Past
Pramod Abcsdd Additional Director 28 Sep 2013 Past
Pramod Abcsdd Director 07 Jul 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Elan Pharma (India).

Elan Pharma (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.68% increase. The company also saw a substantial improvement in profitability, with a 18.65% increase in profit. The company's net worth Soared by an impressive increase of 20.44%.

Elan Pharma (India) revenue growth over time
Elan Pharma (India) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 18.68%
*******
*******
*******
*******
Revenue from Operations
*******
 19.25%
*******
*******
*******
*******
Total Assets
*******
 17.63%
*******
*******
*******
*******
Profit or Loss
*******
 18.65%
*******
*******
*******
*******
Net Worth
*******
 20.44%
*******
*******
*******
*******
EBITDA
*******
 18.24%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Elan Pharma (India)?

In 2023, Elan Pharma (India) had a promoter holding of 96.12% and a public holding of 3.88%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹49,338,124.00

Charges Breakdown by Lending Institutions
  • Canara Bank : 4.93 Cr
Latest Charge Details
Date Lender Amount Status
28 Mar 2006 Canara Bank ₹1.79 Cr Satisfied
04 Feb 2003 Canara Bank ₹0.38 M Satisfied
05 Sep 2001 Canara Bank ₹2.80 Cr Satisfied
05 Sep 2001 Canara Bank ₹1.50 M Satisfied
02 Nov 1999 Canara Bank ₹0.55 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Elan Pharma (India)?

Elan Pharma (India) has a workforce of 321 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Elan Pharma (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elan Pharma (India)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Elan Pharma (India)
Recent Activity within the Organization
  • Annual General Meeting

    The activity Elan Pharma (India) Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Elan Pharma (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.

  • Charges

    Progress on A charge registered on 05 Sep 2001 via Charge ID 90143556 with Canara Bank was fully satisfied on 18 Nov 2020. was documented.

  • Charges

    The activity A charge registered on 28 Mar 2006 via Charge ID 10016391 with Canara Bank was fully satisfied on 30 May 2018. was completed.

  • Charges

    A charge registered on 04 Feb 2003 via Charge ID 90144306 with Canara Bank was fully satisfied on 30 May 2018. was recorded as a recent event.

  • Charges

    A charge registered on 05 Sep 2001 via Charge ID 90146216 with Canara Bank was fully satisfied on 30 May 2018. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Elan Pharma (India) Private Limited?

The CIN of Elan Pharma (India) Private Limited is U24230MH1997PTC108497.

Where is Elan Pharma (India) Private Limited headquartered?

Elan Pharma (India) Private Limited is headquartered at 501-Raikar Chambers Govandi, Deonar,, Mumbai, Maharashtra, 400088.

When was Elan Pharma (India) Private Limited incorporated?

Elan Pharma (India) Private Limited was incorporated on 04 June 1997.

Who are the current directors of Elan Pharma (India) Private Limited?

The current directors of Elan Pharma (India) Private Limited are

What is the primary industry of Elan Pharma (India) Private Limited?

The primary industry of Elan Pharma (India) Private Limited is Manufacturing.

Is Elan Pharma (India) Private Limited a listed company?

Elan Pharma (India) Private Limited is unlisted.

What is the capital structure of Elan Pharma (India) Private Limited?

The authorized capital of Elan Pharma (India) Private Limited is ₹2.50 M, and the paid-up capital is ₹0.94 M.

What is the compliance status of Elan Pharma (India) Private Limited?

The compliance status of Elan Pharma (India) Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available